These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27298560)

  • 1. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.
    Tomer S; Chawla YK; Duseja A; Arora SK
    World J Gastroenterol; 2016 Jun; 22(22):5173-82. PubMed ID: 27298560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.
    Bain C; Fatmi A; Zoulim F; Zarski JP; Trépo C; Inchauspé G
    Gastroenterology; 2001 Feb; 120(2):512-24. PubMed ID: 11159892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.
    Ma L; Zhou Y; Zhang Y; Li Y; Guo Y; He Y; Wang J; Lian J; Hao C; Moorman JP; Yao ZQ; Zhou Y; Jia Z
    Immunology; 2014 Dec; 143(4):670-8. PubMed ID: 24965710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatment.
    Rana D; Chawla YK; Duseja A; Dhiman R; Arora SK
    Liver Int; 2012 Aug; 32(7):1128-37. PubMed ID: 22309109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
    Khedr MA; E Behairy B; Hussein ME; Marei AM; Nage SA; Zakaria HM
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1170-4. PubMed ID: 26148246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy.
    Tsubouchi E; Akbar SM; Murakami H; Horiike N; Onji M
    Clin Exp Immunol; 2004 Aug; 137(2):417-23. PubMed ID: 15270861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes.
    Mengshol JA; Golden-Mason L; Castelblanco N; Im KA; Dillon SM; Wilson CC; Rosen HR;
    Gut; 2009 Jul; 58(7):964-73. PubMed ID: 19193669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Toll-like receptors 7 & 8 mRNA in monocytes of patients with chronic hepatitis C infection: correlation with interferon and ribavirin treatment.
    Boghdadi G; Seleem WM
    Egypt J Immunol; 2014; 21(1):67-75. PubMed ID: 25204046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C.
    Crosignani A; Riva A; Della Bella S
    World J Gastroenterol; 2016 Jan; 22(4):1393-404. PubMed ID: 26819508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy.
    Simone O; Tortorella C; Zaccaro B; Napoli N; Antonaci S
    J Clin Immunol; 2010 Jul; 30(4):556-65. PubMed ID: 20390327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
    Zhang S; Kodys K; Li K; Szabo G
    Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients.
    Shiina M; Kobayashi K; Kobayashi T; Kondo Y; Ueno Y; Shimosegawa T
    J Gastroenterol; 2006 Aug; 41(8):758-64. PubMed ID: 16988764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment.
    Elefsiniotis IS; Vezali E; Kamposioras K; Pantazis KD; Tontorova R; Ketikoglou I; Moulakakis A; Saroglou G
    World J Gastroenterol; 2006 Jul; 12(27):4420-4. PubMed ID: 16865790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection.
    Tsubouchi E; Akbar SM; Horiike N; Onji M
    J Gastroenterol; 2004 Aug; 39(8):754-62. PubMed ID: 15338369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.
    Kim H; Mazumdar B; Bose SK; Meyer K; Di Bisceglie AM; Hoft DF; Ray R
    J Virol; 2012 Sep; 86(18):9919-28. PubMed ID: 22761382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders.
    Carneiro VL; Lemaire DC; Bendicho MT; Souza SL; Cavalcante LN; Angelo AL; Freire SM; Mendes CM; Santana N; Lyra LG; Lyra AC
    Liver Int; 2010 Apr; 30(4):567-73. PubMed ID: 20456039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.
    Hsi E; Huang CF; Dai CY; Juo SH; Chou WW; Huang JF; Yeh ML; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML
    Antiviral Res; 2014 May; 105():135-42. PubMed ID: 24637254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
    Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients.
    Hashad DI; Salem PE; Abdallah DM
    Scand J Clin Lab Invest; 2011 Dec; 71(8):641-6. PubMed ID: 22023039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.